On September 1, 2026, Medtronic, a global medical‑technology giant, and Cornerstone Robotics, a Chinese laparoscopic surgical robot developer, officially announced a deep strategic partnership.
At the Medical‑Health Pavilion of the Changping‑Future Science City exhibition group, Chunfeng Huayu (Beijing) Intelligent Medical Technology Co., Ltd. showcased its self‑developed world‑first three‑arm surgical robot. Boasting its groundbreaking human‑shaped three‑arm architecture and end‑to‑end in
Recently, a domestic‑developed laparoscopic surgical robot has achieved a landmark breakthrough in core‑technology dimensions.
According to a recent announcement on GeRay‑Tech’s official WeChat account, its Newton‑Endo series minimally‑invasive spinal endoscopic surgical robot has successfully completed the world’s first in‑vivo animal experiment with autonomous robotic operation, under the full‑process witness of the team
Recently, the U.S. Food and Drug Administration (FDA) has granted commercialization authorization for Aletta, a fully‑autonomous blood‑collection robot developed by Dutch medical‑robotics firm Vitestro, via the De Novo classification pathway for innovative medical devices.
Invasive brain‑computer interfaces represent the most promising technical pathway for high‑fidelity neuronal signal acquisition and the restoration of impaired neural functions.
Indian surgical‑robotics enterprise SS Innovations delivered an impressive growth performance in the first half of 2026.
Recently, the U.S. has launched a landmark collective research program on autonomous surgical robots.
According to recent official announcements from Gen‑pro Medical, its international expansion has reached a key milestone. The company’s multi‑port laparoscopic surgical robot has completed its first commercial installation and successfully performed the initial clinical operation at Penang Adventist
According to the official update from Tuodao Medical recently, Tuoling®, its self‑developed laparoscopic surgical robot, has successfully completed multiple remote‑control clinical trials in urology, marking a momentous milestone in the development of domestic surgical robots.
On August 3, 2026, Andromeda Surgical, a developer of autonomous surgical robots for urology, announced the completion of its US$15‑million Series‑A financing round.
On August 3, Shanghai Zhudong Technology Co., Ltd. announced the completion of its angel round financing, led by CAS Star. Co-investors include Legend Star, Ventech China, Daotong Investment, Inno Angel Fund, BGI Songhe Life Science Fund, Jifeng Capital and Jiadao Capital.
In January 2026, uSurg DoctorX, the thoracoabdominal endoscopic surgical system under United Imaging Healthcare, secured its first registration approval from the National Medical Products Administration (NMPA), obtaining official regulatory qualification for commercial launch.
On July 23, 2026, Suzhou Sightways Medical Technology Co., Ltd. (referred to as Sightways Robotics) officially announced the completion of its Series A+ financing round, led by Chuanggu Capital.
On July 23, 2026, Momentis Surgical, an Israeli surgical robotics company, officially announced that the multi-port configuration of its Anovo® surgical system has secured U.S. FDA 510(k) clearance.
On July 22, 2026, Johnson & Johnson MedTech announced that its OTTAVA™ Table-Integrated Multi-Port Soft Tissue Surgical Robot has officially received De Novo classification clearance from the U.S. Food and Drug Administration (FDA), authorizing its commercialization in the U.S. market for select upp
In July 2026, the National Health Commission of the People’s Republic of China and two other relevant central departments jointly issued the Circular on Further Improving the Centralized Procurement of Medical Equipment in Public Medical and Health Institutions, which explicitly brought laparoscopic
Long‑dominated by overseas brands that left China with no alternative, the surgical‑robot sector now sees Chinese‑made equipment powering one out of every two robotic‑assisted remote surgeries worldwide. Through over a decade‑long journey of continuous innovation, China’s surgical‑robot industry has
2026-07-14 15:45 |
by
智慧医械网
Recently, Nature published a groundbreaking medical study, in which an engineering and surgical team from the University of California, San Diego (UCSD) accomplished the world‑first‑ever in‑vivo surgical trial performed by a remotely operated humanoid robot.
On July 7, 2026, Japanese surgical robotics company Medicaroid officially announced that its self-developed Hinotori laparoscopic surgical robot has successfully obtained the EU CE-MDR certification.
